Quick Answer
Immuneering Corp reported Gross Profit of $0.00 for fiscal year 2023.
Immuneering Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $158.8K | -82.9% |
| 2021 | $926.9K | -10.1% |
| 2020 | $1.03M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | -100.0% | — |
| June 30, 2023 | $0.00 | -100.0% | — |
| March 31, 2023 | $0.00 | -100.0% | -100.0% |
| September 30, 2022 | $19.0K | -92.8% | -59.0% |
| June 30, 2022 | $46.5K | -86.4% | -49.9% |
| March 31, 2022 | $92.9K | -72.6% | -64.7% |
| September 30, 2021 | $263.0K | -28.4% | -23.0% |
| June 30, 2021 | $341.4K | +40.1% | +0.7% |
- Immuneering Corp showed a decrease of -100.0% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2023 period, Immuneering Corp’s gross profit has declined by 100.0% (from $1.03 million to $0.00).
- The most recent figure is from Immuneering Corp’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: